Skip to main content

Research Insights

Nature and modern science: Phytoneering

We develop and produce evidence based phytotherapeutics, i.e. herbal remedies based on scientific studies and modern research, for decades. In contrast to chemical-synthetic drugs, the active ingredients in herbal drugs does not consist of a single isolated substance. Herbal medicinal products are complex multi-substance mixtures, where every single substance makes up its active ingredient.
As the quality and efficacy of an herbal preparation largely depends on its ingredients, we set the highest standards for our herbal raw materials. We ensure the constant quality of the plants through controlled and standardized cultivation. Ecologically sustainable cultivation and short transport routes are our priorities. All stages of the manufacturing process are accompanied by analytical regulations. This is a complex system that makes our medicinal plants unique.

Our products combine the knowledge of traditional medicinal plant therapy with the forward-looking results of scientific research. We call this combination between nature (phytos = plant) and science (engineering) Phytoneering. We apply this principle at all stages of the manufacturing process. In the case of herbal medicinal products in particular, the manufacturing process plays a major role in the efficacy of the medication. With our cultivation, extraction and production processes, we set standards globally.

Determining efficacy

research and developement
The mode of action and tolerability of Bionorica products is examined in pharmacological and clinical studies while considering the latest findings in molecular biology. In addition, results from preclinical and clinical trials by leading scientists in the phytopharmacological field are directly incorporated for the improvement of special extracts and products. In this way, the conditions for the international approval of the pharmaceuticals are created.

Our Network

We cooperate with approx. 500 leading institutes, clinics and universities worldwide. In addition to our Innsbruck based subsidiary Bionorica research GmbH, the Michael Popp Research Institute for new Phyto Entities and the cooperation with the Austrian Drug Screening Institute (ADSI) in Austria, there are many other research collaborations with renowned institutes and universities. Here is a selection:

our network